2-(2-(3,5-Dibromo-1H-1,2,4-triazol-1-yl)ethyl)isoindoline-1,3-dione

Catalog No.: 
ACAMPA972
CAS No.: 
1240567-39-8
Molecular Formula: 
C12H8Br2N4O2
Molecular Weight: 
400.03
2-(2-(3,5-Dibromo-1H-1,2,4-triazol-1-yl)ethyl)isoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-(3,5-Dibromo-1H-1,2,4-triazol-1-yl)ethyl)isoindoline-1,3-dione
IUPAC Name2-(2-(3,5-dibromo-1H-1,2,4-triazol-1-yl)ethyl)isoindoline-1,3-dione
Molecular FormulaC12H8Br2N4O2
Molecular Weight400.03
SMILESO=C1N(CCN2N=C(Br)N=C2Br)C(C3=C1C=CC=C3)=O
InChI KeyQVPMIERVPMCKAQ-UHFFFAOYSA-N
Synonym2-[2-(3,5-dibromo-1H-1,2,4-triazol-1-yl)ethyl]-2,3-dihydro-1H-isoindole-1,3-dione;1H-Isoindole-1,3(2H)-dione, 2-[2-(3,5-dibromo-1H-1,2,4-triazol-1-yl)ethyl]-
CAS No.1240567-39-8

Synthetic Route by SureRoute

1. ACAMPA972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJIES258 route compound structure diagram
    ACJIES2587411-23-6In Stock
  2. Plus
  3. ACHZTP712 route compound structure diagram
    ACHZTP712574-98-1In Stock
  4. Then
  5. ACAMPA972 route product structure diagram
    ACAMPA9721240567-39-8
Inquiry

2. ACAMPA972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAMPA972 route product structure diagram
    ACAMPA9721240567-39-8
Inquiry

3. ACAMPA972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4In Stock
  4. Then
  5. ACAMPA972 route product structure diagram
    ACAMPA9721240567-39-8
Inquiry

Comments (0)